BACKGROUND Aplasia cutis congenita (ACC) in newborns is a condition in which congenital defects or hypoplasia is present in part of the epidermis,dermis and even subcutaneous tissue (including muscle and bones).First ...BACKGROUND Aplasia cutis congenita (ACC) in newborns is a condition in which congenital defects or hypoplasia is present in part of the epidermis,dermis and even subcutaneous tissue (including muscle and bones).First reported by Cordon in 1767,ACC is a rare disease with a low incidence of 1/100000 to 3/10000.Currently,there are 500 cases reported worldwide.ACC can be accompanied by other malformations.The onset mechanism of the disease remains unknown but is thought to be correlated to factors such as genetics,narrow uterus,foetal skin and amniotic membrane adhesion,use of teratogenic drugs in early pregnancy and viral infection.CASE SUMMARY In August 2018,we treated a newborn with ACC on the left lower limbs using a combination of ionic silver dressing and moist exposed burn ointment (MEBO) and achieved a satisfactory treatment outcome.The skin defects were observed on the external genitals and on areas from the left foot to 3/4 of the upper left side.Subcutaneous tissue and blood vessels were observed in the regions with skin defects.The following treatments were provided.First,the wound was rinsed with 0.9% sodium chloride solution followed by disinfection with povidone-iodine twice.And then MEBO was applied to the wound at a thickness of approximately 1 mm.After applying ionic silver dressing,the wound was covered with sterile gauze.The wound dressing was replaced every 2-3 d.At the 4-mo follow-up,the treatment outcome was satisfactory.There was minimal scar tissue formation,and limb function was not impaired.CONCLUSION The combination of ionic silver dressing and MEBO to ACC is helpful.展开更多
Objective:To discuss the main active components and potential mechanisms of moist burn ointment in the treat-ment of diabetic ulcer were discussed by network pharmacology and molecular docking technology.Methods:Based...Objective:To discuss the main active components and potential mechanisms of moist burn ointment in the treat-ment of diabetic ulcer were discussed by network pharmacology and molecular docking technology.Methods:Based on the TC-MSP database,the main active components and targets of MEBO were screened.The targets related to diabetic ulcers were searched from GeneCards,OMIM,PharmGkb,TTD,and DrugBank databases.The STRING 11.5 database was used to con-struct a protein-protein interaction(PPI)network to screen the core targets.The'drug-target-disease'network diagram was made in Cytoscape 3.8.2 software to screen the core active components.GO enrichment analysis and KEGG pathway enrichment analysis were performed using R language software.Finally,molecular docking was used to preliminarily verify the screening results.Results:A total of 37 active components of MEBO were screened to map 100 targets,5527 targets for diabetic ulcer dis-ease,and 77 intersection targets.PPI network topology analysis suggested that TP53,TNF,HSP90AA1 and other targets were key targets;the network diagram of ‘drug-target-disease’showed that acacetin,wogonin,quercetin,and rutaecarpine were the core active ingredients.GO function analysis mainly involved angiogenesis,ion transport,diameter regulation,cytokine receptor binding,and other processes.KEGG enrichment analysis mainly included PI3K-Akt,AGE-RAGE,and other signaling pathways.Molecular docking showed that the core active ingredients and key targets had good docking activity.Conclusion:The treatment of diabetic ulcer with MEBO is the result of multi-component,multi-target,and synergistic regulation,which provides a theoretical basis for the clinical application of MEBO and the treatment of diabetic ulcer.展开更多
目的:探究积雪苷霜软膏联合点阵CO_(2)激光对面部烧伤后增生性瘢痕(Hypertrophic scar,HS)的临床疗效。方法:选取2020年7月-2022年7月宿迁市第一人民医院收治的80例面部烧伤后HS患者为研究对象,按照随机数字表法将其分为对照组(n=40)和...目的:探究积雪苷霜软膏联合点阵CO_(2)激光对面部烧伤后增生性瘢痕(Hypertrophic scar,HS)的临床疗效。方法:选取2020年7月-2022年7月宿迁市第一人民医院收治的80例面部烧伤后HS患者为研究对象,按照随机数字表法将其分为对照组(n=40)和观察组(n=40),对照组给予点阵CO_(2)激光治疗,观察组在对照组基础上联合积雪苷霜软膏治疗,连续治疗6个月,比较两组患者临床疗效,以及治疗前后改良温哥华瘢痕评估量表(Modified Vancouver scar scale,mVSS)、瘢痕血流灌注量、瘢痕厚度和烧伤健康量表(Burns specific health scale-brief,BSHS-B)评分,记录不良反应发生情况。结果:观察组临床总有效率(92.50%)较对照组(72.50%)高(P<0.05);治疗前,两组患者色泽、厚度、柔软度、血管分布、瘙痒、疼痛及mVSS总分比较差异无统计学意义(P>0.05),治疗后,两组患者上述评分均降低,且观察组较对照组更低(P<0.05);治疗前,两组患者瘢痕血流灌注量、瘢痕厚度及BSHS-B各维度评分比较差异无统计学意义(P>0.05),治疗后,两组患者瘢痕血流灌注量、瘢痕厚度均降低,BSHS-B各维度评分均升高,且观察组优于对照组(P<0.05);两组患者不良反应总发生率对比差异无统计学意义(P>0.05)。结论:面部烧伤后HS患者应用积雪苷霜软膏联合点阵CO_(2)激光治疗,疗效显著,可明显改善mVSS评分、瘢痕血流灌注量及瘢痕厚度,提高生存质量,且安全性良好。展开更多
文摘BACKGROUND Aplasia cutis congenita (ACC) in newborns is a condition in which congenital defects or hypoplasia is present in part of the epidermis,dermis and even subcutaneous tissue (including muscle and bones).First reported by Cordon in 1767,ACC is a rare disease with a low incidence of 1/100000 to 3/10000.Currently,there are 500 cases reported worldwide.ACC can be accompanied by other malformations.The onset mechanism of the disease remains unknown but is thought to be correlated to factors such as genetics,narrow uterus,foetal skin and amniotic membrane adhesion,use of teratogenic drugs in early pregnancy and viral infection.CASE SUMMARY In August 2018,we treated a newborn with ACC on the left lower limbs using a combination of ionic silver dressing and moist exposed burn ointment (MEBO) and achieved a satisfactory treatment outcome.The skin defects were observed on the external genitals and on areas from the left foot to 3/4 of the upper left side.Subcutaneous tissue and blood vessels were observed in the regions with skin defects.The following treatments were provided.First,the wound was rinsed with 0.9% sodium chloride solution followed by disinfection with povidone-iodine twice.And then MEBO was applied to the wound at a thickness of approximately 1 mm.After applying ionic silver dressing,the wound was covered with sterile gauze.The wound dressing was replaced every 2-3 d.At the 4-mo follow-up,the treatment outcome was satisfactory.There was minimal scar tissue formation,and limb function was not impaired.CONCLUSION The combination of ionic silver dressing and MEBO to ACC is helpful.
基金National Natural Science Foundation Project (No.81774327)Guangxi Graduate Education Innovation Program Project (No.YCSW2023496)+1 种基金The"139"Plan for Senior and Secondary Backbone Talents in Guangxi Medicine (No.Gui Wei Ke Jiao Fa[2018]No.22)Graduate Innovation Program Project of Youjiang Ethnic Medical College (No.YXCXJH2022004)。
文摘Objective:To discuss the main active components and potential mechanisms of moist burn ointment in the treat-ment of diabetic ulcer were discussed by network pharmacology and molecular docking technology.Methods:Based on the TC-MSP database,the main active components and targets of MEBO were screened.The targets related to diabetic ulcers were searched from GeneCards,OMIM,PharmGkb,TTD,and DrugBank databases.The STRING 11.5 database was used to con-struct a protein-protein interaction(PPI)network to screen the core targets.The'drug-target-disease'network diagram was made in Cytoscape 3.8.2 software to screen the core active components.GO enrichment analysis and KEGG pathway enrichment analysis were performed using R language software.Finally,molecular docking was used to preliminarily verify the screening results.Results:A total of 37 active components of MEBO were screened to map 100 targets,5527 targets for diabetic ulcer dis-ease,and 77 intersection targets.PPI network topology analysis suggested that TP53,TNF,HSP90AA1 and other targets were key targets;the network diagram of ‘drug-target-disease’showed that acacetin,wogonin,quercetin,and rutaecarpine were the core active ingredients.GO function analysis mainly involved angiogenesis,ion transport,diameter regulation,cytokine receptor binding,and other processes.KEGG enrichment analysis mainly included PI3K-Akt,AGE-RAGE,and other signaling pathways.Molecular docking showed that the core active ingredients and key targets had good docking activity.Conclusion:The treatment of diabetic ulcer with MEBO is the result of multi-component,multi-target,and synergistic regulation,which provides a theoretical basis for the clinical application of MEBO and the treatment of diabetic ulcer.
文摘目的:探究积雪苷霜软膏联合点阵CO_(2)激光对面部烧伤后增生性瘢痕(Hypertrophic scar,HS)的临床疗效。方法:选取2020年7月-2022年7月宿迁市第一人民医院收治的80例面部烧伤后HS患者为研究对象,按照随机数字表法将其分为对照组(n=40)和观察组(n=40),对照组给予点阵CO_(2)激光治疗,观察组在对照组基础上联合积雪苷霜软膏治疗,连续治疗6个月,比较两组患者临床疗效,以及治疗前后改良温哥华瘢痕评估量表(Modified Vancouver scar scale,mVSS)、瘢痕血流灌注量、瘢痕厚度和烧伤健康量表(Burns specific health scale-brief,BSHS-B)评分,记录不良反应发生情况。结果:观察组临床总有效率(92.50%)较对照组(72.50%)高(P<0.05);治疗前,两组患者色泽、厚度、柔软度、血管分布、瘙痒、疼痛及mVSS总分比较差异无统计学意义(P>0.05),治疗后,两组患者上述评分均降低,且观察组较对照组更低(P<0.05);治疗前,两组患者瘢痕血流灌注量、瘢痕厚度及BSHS-B各维度评分比较差异无统计学意义(P>0.05),治疗后,两组患者瘢痕血流灌注量、瘢痕厚度均降低,BSHS-B各维度评分均升高,且观察组优于对照组(P<0.05);两组患者不良反应总发生率对比差异无统计学意义(P>0.05)。结论:面部烧伤后HS患者应用积雪苷霜软膏联合点阵CO_(2)激光治疗,疗效显著,可明显改善mVSS评分、瘢痕血流灌注量及瘢痕厚度,提高生存质量,且安全性良好。
